Andrew Godwin
Dr. Godwin is a leader in the field of translational research and precision medicine, and his laboratories at KUMC continue to focus on various aspects of both basic and translational research. He is a NCI funded investigator (continuously since 1993) and a highly published (>380 manuscripts and scholarly review articles) and cited (>33,500; h-index of 97) scientist. Dr. Godwin is internationally recognized for his molecular biology/genetic studies of cancers including, sarcoma, breast and ovarian, and his efforts to help bridge the gap between basic and clinical science in order to improve patient care. Through the CMOL and BDL, Godwin's group continues to support the development and advancement of rationally designed therapeutic strategies to improve the options for patient treated at the KU Cancer Center.
